Analysis of Morphology, Immunology, Cytogentic and Molecular Biology Classification of Patients with Chronic Myeloid Leukemia in Blastic Crisis

YUAN Cui-ying,ZHOU Min,XIE Pin-hao,ZHANG Qian,DONG Hai-bo,CHE Lan-xin,OUYANG Jian
DOI: https://doi.org/10.13241/j.cnki.pmb.2011.19.026
2011-01-01
Abstract:Objective: To invistigate the characteristic and value of bone marrow morphology,immunology,cytogenetic and molecular biology(MICM) in patients with chronic myeloid leukemia in blastic crisis(CML-BC).Methods: 38 patients with CML-BC were studied by MICM analysis.Results: The accuracy rate of morphological diagonis based on FBA classification was 94.7%.Immunol-ogy results,the percentage of CML-AMLwas 71.0%,in which 37.0% patients expressed lympholytic associated antigen;The percentage of CML-ALL was 23.7% and all were B lypholytic immunophenotype,in which 66.7% patients expressed myeloid assuiated antigen;The percentage of CML-MALwas 5.3% with all expressing B lypholoid and myeloid immumphenotype.26 cases(68.4%) had CD34 expres-sion and 10 cases(26.3%) had CD7 and CD34 Co-expression.In cytogenetic result,the positive rate of Ph chromosome was 94.3%.Oth-er chromosome abnomality rate was 60.5% with +ph,+8 and i(17q) in high appearance rate.The positive rate of BCR /ABL gene by FISH reached 100% with 14.7% del(9).The positive rate of BCR /ABLgene by RT-PCR also reached 100% with b2a3(12/20),b3a2(8/20) and b2a3+b3a2(1/20).Conclusion: CML-BC is a kind of disease of stem cell.The differentiation of blast cell is blocked in the early stage.MICM has great value in diangnosis,therapy and prognosis judgement.
What problem does this paper attempt to address?